This was a good week for Hollingsworth. The firm, which serves as national counsel for Novartis in ongoing litigation involving the osteoporosis drugs Aredia and Zometa, prevailed for its clients in New York and Rhode Island. Plaintiffs claim that the Novartis medications cause serious jaw injuries.
Last month, the Ohio Supreme Court declined to hear the appeal of plaintiffs law firm Motley Rice in a lawsuit that alleges confidential documents were stolen from Sherwin-Williams.
A trial lawyer whose long-standing judicial nomination was confirmed this week by the Senate will likely begin his tenure in U.S. District Court in Rhode Island by early July.